首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

ADVANCES IN THERAPY
ISSN：0741-238X

ADVANCES IN THERAPY

ADV THER
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：较慢,6-12周
新锐分区：医学2区
年发文量：306
影响因子：4.1
JCR分区：Q1

基本信息

《治疗进展》是一本国际性、同行评审、快速出版（2周内完成同行评审，接受后3-4周内出版）期刊，致力于出版高质量的临床（所有阶段）、观察性、真实世界和健康结局研究，这些研究围绕所有治疗领域的治疗和干预（包括器械）的发现、开发和使用。同时，也鼓励与诊断学、药物经济学、公共卫生、流行病学、生活质量、患者护理、管理和教育相关的研究。该杂志是广大医疗保健专业人士感兴趣的杂志，发表原创研究、评论、通信和信件。该杂志面向全球读者，并收到来自世界各地的投稿。《治疗进展》将考虑所有科学上合理的研究，无论是阳性、确证性或阴性数据。无论是针对国际和/或特定国家的受众，我们都欢迎提交材料，当研究人员试图针对更特定的患者人群时，这一点至关重要。这种包容性的方法使该杂志能够协助传播所有科学和道德上健全的研究。
0741-238XSCIE/Scopus收录
4.1
点击查看最新影响趋势>
4.5
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
2区
PHARMACOLOGY & PHARMACY 药学
2区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
Q2
60/195
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
79/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
Q2
66/195
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
107/353
53
306
点击查看年发文量趋势图>
7%较易较慢,6-12周-医学-药学
4.9%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
84.31%71.67%4.71%
CiteScore：7.20
SJR：1.236
SNIP：1.380
学科类别分区排名百分位
大类：Medicine
小类：Pharmacology (medical)
Q1
49 / 275

期刊高被引文献

Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00981-y
Analgesic Efficacy, Practicality and Safety of Inhaled Methoxyflurane Versus Standard Analgesic Treatment for Acute Trauma Pain in the Emergency Setting: A Randomised, Open-Label, Active-Controlled, Multicentre Trial in Italy (MEDITA)
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01055-9
Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-0895-1
Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01008-2
Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00899-5
A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01015-3
Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes
来源期刊：Advances in TherapyDOI：10.1007/s12325-018-0868-9
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00908-7
Clinical Application of LC–MS/MS in the Follow-Up for Treatment of Children with Methylmalonic Aciduria
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00955-0
Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01017-1
Management of Fibrosing Interstitial Lung Diseases
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00992-9
Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00906-9
Absolute Bioavailability of Esaxerenone and Food Effects on its Pharmacokinetics After a Single Oral Dose in Healthy Japanese Subjects: An Open-Label Crossover Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00956-z
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01145-8
Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01157-4
Subgroup Analysis for Chinese Patients Included in the INPULSIS® Trials on Nintedanib in Idiopathic Pulmonary Fibrosis
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-0887-1
The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00965-y
Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01124-z
Liaoning Score for Prediction of Esophageal Varices in Cirrhotic Patients Who Had Never Undergone Endoscopy: A Multicenter Cross-Sectional Study in Liaoning Province, China
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00967-w
Population Pharmacokinetic Analysis of Bintrafusp Alfa in Different Cancer Types
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01018-0
Transbronchial Lung Cryobiopsy in Idiopathic Pulmonary Fibrosis: A State of the Art Review
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01036-y
Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00976-9
Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00907-8
Understanding the Patient Perception of Statin Experience: A Qualitative Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01073-7
Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01075-5
Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00974-x
Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01058-6
The Association Between Type 2 Diabetes and Cardiovascular Disease: The “For Your SweetHeart™” Survey
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-0871-9
Intravitreal Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Associated with Rare Diseases: Cost-Effectiveness in the UK
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-0894-2
Factors Determining the Choice of Spinal Versus General Anesthesia in Patients Undergoing Ambulatory Surgery: Results of a Multicenter Observational Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01171-6
Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-0890-6
Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01112-3
Surgery for Idiopathic Epimacular Membrane: Morpho-Functional Outcomes Based on the Preoperative Macular Integrity of the Photoreceptoral Junction. A Prospective Pilot Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01165-4
Impact of Chloroprocaine on the Eligibility for Hospital Discharge in Patients Requiring Ambulatory Surgery Under Spinal Anesthesia: An Observational Multicenter Prospective Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01172-5
Association Between Residual Platelet Reactivity on Clopidogrel Treatment and Severity of Coronary Atherosclerosis: Intrinsic Hypercoagulability as a Mediator
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01032-2
The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00935-4
Reporting Clinical Trial Results of Phytomedicines in Acute Rhinosinusitis: Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi: 10.1007/s12325-018-0736-7
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00933-6
Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00910-z
Recognising Skin Cancer in Primary Care
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01130-1
Survival, Chemotherapy Treatments, and Health Care Utilization Among Patients with Advanced Small Cell Lung Cancer: An Observational Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01161-8
Identification of Chinese Hospitalized Patients’ Risk Profile for Venous Thromboembolism (DissolVE1): A Study Protocol of a Non-Interventional Registry Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00987-6
Correction to: Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-0892-4
Response Letter Addressing Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi:10.1007/s12325-018-0736-7
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00934-5
Methylmalonic Acidemia Complicated by Homocystinuria Diseases: a Report of Three Cases
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01149-4
Stepwise Decreasing of Vitreous Pressure by Anterior Vitrectomy: A Novel Method for Preventing Positive Vitreous Pressure During Penetrating Keratoplasty
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01139-6
Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01195-y
COPD Exacerbations: A Patient and Physician’s Perspective
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01138-7
Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-00993-8
Claros System: A Rapid Microfluidics-Based Point-of-Care System for Quantitative Prostate Specific Antigen Analysis from Finger-Stick Blood
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-0888-0
Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
来源期刊：Advances in TherapyDOI：10.1007/s12325-019-01082-6

相关文章

Advances in Therapy：影响因子4.0，中科院3区，临床治疗方向，年发文300+，较易录用，审稿速度2-3月，自引率2.5%无预警风险。
2025-09-10
ADVANCES IN THERAPY：期刊质量在线，无需担心灌水～
2025-08-07
Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15

期刊推荐

ACADEMIC EMERGENCY MEDICINE封面

ACADEMIC EMERGENCY MEDICINE

学科领域：医学
影响因子：3.2
中科院分区： 2区
ACADEMIC RADIOLOGY封面

ACADEMIC RADIOLOGY

学科领域：医学
影响因子：3.9
中科院分区： 2区
APPETITE封面

APPETITE

学科领域：医学
影响因子：3.8
中科院分区： 2区
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA封面

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

学科领域：医学
影响因子：3.1
中科院分区： 2区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
2区
PHARMACOLOGY & PHARMACY 药学
2区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否